Companies House true 2023-02-22 2024-02-28 false 14681859 uk-bus:Director1 2023-02-22 2024-02-28 14681859 uk-bus:Director2 2023-02-22 2024-02-28 14681859 2023-02-22 2024-02-28 14681859 2024-02-28 14681859 uk-bus:EntityHasNeverTraded 2023-02-22 2024-02-28 14681859 uk-bus:FRS102 2023-02-22 2024-02-28 14681859 uk-bus:FullAccounts 2023-02-22 2024-02-28 14681859 uk-bus:AuditExempt-NoAccountantsReport 2023-02-22 2024-02-28 14681859 uk-bus:OrdinaryShareClass1 2023-02-22 2024-02-28 14681859 uk-bus:OrdinaryShareClass2 2023-02-22 2024-02-28 14681859 uk-bus:OrdinaryShareClass3 2023-02-22 2024-02-28 14681859 uk-bus:PreferenceShareClass1 2023-02-22 2024-02-28 14681859 uk-bus:PreferenceShareClass2 2023-02-22 2024-02-28 14681859 uk-bus:PreferenceShareClass3 2023-02-22 2024-02-28 14681859 uk-core:ShareCapitalPreferenceShares 2024-02-28 iso4217:GBP iso4217:GBP xbrli:shares xbrli:shares

Registered Number 14681859

GSK CROSS STREET LTD

Dormant Accounts

28 February 2024

GSK CROSS STREET LTD Registered Number 14681859

Balance Sheet as at 28 February 2024

2024
£
Current assets
Cash at bank and in hand
10
Net assets
10
Issued share capital
10 Ordinary Shares of £ 1 each 10
Total Shareholder funds
10

STATEMENTS

  1. For the year ending 28 February 2024 the company was entitled to exemption under section 480 of the Companies Act 2006 relating to dormant companies.
  2. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
  3. The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
  4. These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

Approved by the Board on 1 May 2024

And signed on their behalf by:
Gary Stephen Kedgley, Director